Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ferrous ascorbate + folic acid + zinc sulfate (Medley Pharmaceuticals)
- Development stage
- Unknown
- Lead developer
- Medley
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
R.B. Tone XT is an approved, oral, film-coated haematinic combination tablet manufactured by Medley Pharmaceuticals. It is formulated with ferrous ascorbate (equivalent to 100 mg elemental iron), folic acid (1500 mcg), and zinc sulfate monohydrate (equivalent to 22.5 mg elemental zinc). This combination is primarily indicated for the treatment and prevention of pregnancy-induced anaemia, general weakness, and iron, folic acid, and zinc deficiency states. Ferrous ascorbate provides a highly bioavailable and stable chelate of iron and vitamin C, which enhances iron absorption while minimizing gastrointestinal side effects. Folic acid is essential for red blood cell formation, DNA synthesis, and fetal neural tube development, while zinc supports maternal immune function, fetal growth, and neurobehavioral development.
- Brand names
- R.B. Tone XT
- Other names
- R.B. Tone XT Tabletferrous ascorbate + folic acid + zinc sulphate
02
Targets
DHFR (Dihydrofolate reductase)FOLR1 (FRα)GPR39 (G protein-coupled receptor 39)
Beyond the preview
Go deeper on ferrous ascorbate + folic acid + zinc sulfate (Medley Pharmaceuticals).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ferrous ascorbate + folic acid + zinc sulfate (Medley Pharmaceuticals).